Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses versus Continuous Infusion in Septic Shock: A Prospective Randomized Trial.

Ram GK, Shekhar S, Singh RB, Anand R, De RR, Kumar N

Open source

DOI
10.4103/aer.aer_115_22
Published
2022 Jul-Sep
Container
Anesthesia, essays and researches
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4103/aer.aer_115_22,
  title = {Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses versus Continuous Infusion in Septic Shock: A Prospective Randomized Trial.},
  author = {Ram GK and Shekhar S and Singh RB and Anand R and De RR and Kumar N},
  year = {2022},
  journal = {Anesthesia, essays and researches},
  doi = {10.4103/aer.aer_115_22},
  url = {https://doi.org/10.4103/aer.aer_115_22}
}

RIS

TY  - JOUR
TI  - Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses versus Continuous Infusion in Septic Shock: A Prospective Randomized Trial.
AU  - Ram GK
AU  - Shekhar S
AU  - Singh RB
AU  - Anand R
AU  - De RR
AU  - Kumar N
PY  - 2022
JO  - Anesthesia, essays and researches
DO  - 10.4103/aer.aer_115_22
UR  - https://doi.org/10.4103/aer.aer_115_22
ER  - 

APA

GK, R., S, S., RB, S., R, A., RR, D., & N, K. (2022). Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses versus Continuous Infusion in Septic Shock: A Prospective Randomized Trial.. Anesthesia, essays and researches. https://doi.org/10.4103/aer.aer_115_22

Source records